Glaukos GKOS
NYSE GKOS
$247.18 +10.99 (+4.65%)
As of: Nov 11, 2026 · 3:59 PM EST

Glaukos (GKOS) Asset Writedowns and Impairment (2025 - 2026)

Updated

Analysis

Glaukos (GKOS) Asset Writedowns and Impairment (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn
10 Glaukos 13.97 Bn 13.50 Bn 179.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 51,000.00
Dec 31, 2025 112.87 Mn
API Access

Glaukos Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=GKOS&period=max&api_key=YOUR_API_KEY